AlsaneaO, WadaN, AinK, WongM, TaylorK, ItuartePH, TreselerPA, WeierHU, FreimerN, SipersteinAE, DuhQY, TakamiH, ClarkOH. 2000. Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multi-center series. Surgery, 128:1043–1050.
3.
RobenshtokE, TzvetovG, Grozinsky-GlasbergS, Shraga-SlutzkyI, WeinsteinR, LazarL, SerovS, SingerJ, HirschD, ShimonI, BenbassatC. 2011. Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study. Thyroid, 21:43–48.
4.
TriponezF, WongM, SturgeonC, CaronN, GinzingerDG, SegalMR, KebebewE, DuhQY, ClarkOH. 2006. Does familial non-medullary thyroid cancer adversely affect survival?. World J Surg, 30:787–793.
5.
MazehH, BenavidezJ, PoehlsJL, YoungwirthL, ChenH, SippelRS. 2012. In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease. Thyroid, 22:3–8.
